The role of zinc transporter ZIP4 in prostate carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 6, 2012, Pages 906-911

  Chen, Qi guang ^a   Zhang, Zhe ^a   Yang, Qi ^a   Shan, Guang yi ^a   Yu, Xiu yue ^a   Kong, Chui ze ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoma; Invasion; Proliferation; Prostate; Tumor suppressor gene; Zinc transporter; ZIP4

Indexed keywords

MESSENGER RNA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER PROTEIN ZIP4;

ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DISEASE ASSOCIATION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA; CATION TRANSPORT PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84870482629     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.11.010     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Isaacs W.B., Bova G.S. Prostate cancer. The genetic basis of human cancer 1998, 653-660. McGraw-Hill, New York. B. Vogelstein, K. Kinzler (Eds.).
3. Thompson T.C., Timme T.L., Bangma C.H., et al. Molecular biology of prostate cancer. Genitourinary oncology 2000, 563-564. LW&W, Philadelphia. 2nd ed. N.J. Vogelzang, P.T. Scardino, W.U. Shipley (Eds.).
4. Prasad A.S., Halsted J.A., Nadimi M. Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism, and geophagia. Am J Med 1961, 31:532-546.
5. Mao X., Kim B.E., Wang F., et al. A histidine-rich cluster mediates the ubiquitination and degradation of the human zinc transporter, hZIP4, and protects against zinc cytotoxicity. J Biol Chem 2007, 282:6992-7000.
6. Kagara N., Tanaka N., Noguchi S., et al. Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells. Cancer Sci 2007, 98:692-697.
7. Krebs N.F., Hambidge K.M. Zinc requirements and zinc intakes of breast-fed infants. Am J Clin Nutr 1986, 43288-43292.
8. Li M., Zhang Y., Liu Z., et al. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A 2007, 104:18636-18641.
9. Chakravarty P.K., Ghosh A., Chowdhury J.R. Zinc in human malignancies. Neoplasma 1986, 33:85-90.
10. Gupta S.K., Singh S.P., Shukla V.K. Copper, zinc, and Cu/Zn ratio in carcinoma of the gallbladder. J Surg Oncol 2005, 91:204-208.
11. Tashiro H., Kawamoto T., Okubo T., et al. Variation in the distribution of trace elements in hepatoma. Biol Trace Elem Res 2003, 95:49-63.
12. Costello L.C., Franklin R.B. The clinical relevance of the metabolism of prostate cancer; zinc, and tumor suppression: Connecting the dots. Mol Cancer 2006, 5:17.
13. Kim B.E., Wang F., Dufner-Beattie J., et al. Zn2+-stimulated endocytosis of the mZIP4 zinc transporter regulates its location at the plasma membrane. J Biol Chem 2004, 279:4523-4530.
14. Liuzzi J.P., Cousins R.J. Mammalian zinc transporters. Annu Rev Nutr 2004, 24:151-172.
15. Guerinot M.L. The ZIP family of metal transporters. Biochim Biophys Acta 2000, 1465:190-198.
16. Eide D.J. The SLC39 family of metal ion transporters. Pflugers Arch 2004, 447:796-800.
17. Desouki M.M., Geradts J., Milon B., et al. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol Cancer 2007, 6:37.
18. Franklin R.B., Ma J., Zou J., et al. Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorg Biochem 2003, 96:435-442.
19. Schmitt S., Küry S., Giraud M., et al. An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica. Hum Mutat 2009, 30:926-933.
20. Küry S., Dréno B., Bézieau S., et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002, 31:239-240.
21. Auld D.S. Zinc coordination sphere in biochemical zinc sites. Biometals 2001, 14:271-313.
22. Feustel A., Wennrich R., Steiniger D., et al. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol Res 1982, 10:301-303.
23. Ogunlewe J.O., Osegbe D.N. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 1989, 63:1388-1392.
24. Franklin R.B., Costello L.C. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 2007, 463:211-217.
25. Franklin R.B., Milon B., Feng P., et al. Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer. Front Biosci 2005, 10:2230-2239.
26. Chesters J.K., Boyne R. Nature of the Zn2+ requirement for DNA synthesis by 3T3 cells. Exp Cell Res 1991, 192:631-634.
27. Kim A.H., Sheline C.T., Tian M., et al. L-type Ca(2+) channel-mediated Zn(2+) toxicity and modulation by ZnT-1 in PC12 cells. Brain Res 2000, 886:99-107.
28. Huang S., Pettaway C.A., Uehara H., et al. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001, 20:4188-4197.
29. Kim C.H., Kim J.H., Lee J., et al. Zinc-induced NF-κB inhibition can be modulated by changes in the intracellular metallothionein level. Toxicol Appl Pharmacol 2003, 190:189-196.
30. Ishii K., Otsuka T., Iguchi K., et al. Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett 2004, 207:79-87.